A detailed history of Price T Rowe Associates Inc transactions in Omnicell, Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 40,883 shares of OMCL stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,883
Previous 40,450 1.07%
Holding current value
$1.87 Million
Previous $1.1 Million 62.83%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$25.61 - $45.43 $11,089 - $19,671
433 Added 1.07%
40,883 $1.78 Million
Q2 2024

Aug 14, 2024

BUY
$26.22 - $32.65 $42,030 - $52,337
1,603 Added 4.13%
40,450 $1.1 Million
Q1 2024

May 15, 2024

SELL
$26.15 - $37.33 $7.02 Million - $10 Million
-268,375 Reduced 87.36%
38,847 $1.14 Million
Q4 2023

Feb 14, 2024

SELL
$29.24 - $45.81 $107,486 - $168,397
-3,676 Reduced 1.18%
307,222 $11.6 Million
Q3 2023

Nov 14, 2023

SELL
$44.6 - $73.38 $4.13 Million - $6.8 Million
-92,628 Reduced 22.95%
310,898 $14 Million
Q2 2023

Aug 14, 2023

SELL
$57.88 - $75.94 $160,038 - $209,974
-2,765 Reduced 0.68%
403,526 $29.7 Million
Q1 2023

May 15, 2023

SELL
$51.51 - $60.43 $4.6 Million - $5.39 Million
-89,244 Reduced 18.01%
406,291 $23.8 Million
Q4 2022

Feb 14, 2023

BUY
$46.24 - $90.03 $135,390 - $263,607
2,928 Added 0.59%
495,535 $25 Million
Q3 2022

Nov 14, 2022

BUY
$84.23 - $117.38 $240,476 - $335,119
2,855 Added 0.58%
492,607 $42.9 Million
Q2 2022

Aug 15, 2022

SELL
$105.64 - $129.11 $3.56 Million - $4.36 Million
-33,741 Reduced 6.45%
489,752 $55.7 Million
Q1 2022

May 16, 2022

SELL
$120.68 - $180.51 $4.35 Million - $6.5 Million
-36,020 Reduced 6.44%
523,493 $67.8 Million
Q4 2021

Feb 14, 2022

SELL
$153.26 - $183.62 $7.05 Million - $8.45 Million
-46,000 Reduced 7.6%
559,513 $101 Million
Q3 2021

Nov 15, 2021

SELL
$141.84 - $160.88 $5.25 Million - $5.96 Million
-37,024 Reduced 5.76%
605,513 $89.9 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $151.45 $8.33 Million - $9.71 Million
-64,087 Reduced 9.07%
642,537 $97.3 Million
Q1 2021

May 17, 2021

SELL
$117.78 - $143.9 $2.02 Million - $2.47 Million
-17,166 Reduced 2.37%
706,624 $91.8 Million
Q4 2020

Feb 16, 2021

BUY
$73.85 - $120.02 $53.5 Million - $86.9 Million
723,790 New
723,790 $86.9 Million

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $2.02B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.